AIDX Stock Overview
Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Healwell AI Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.90 |
52 Week High | CA$1.25 |
52 Week Low | CA$0.085 |
Beta | -0.58 |
1 Month Change | 1.12% |
3 Month Change | 28.57% |
1 Year Change | 80.00% |
3 Year Change | -68.20% |
5 Year Change | n/a |
Change since IPO | -80.09% |
Recent News & Updates
Shareholder Returns
AIDX | CA Healthcare | CA Market | |
---|---|---|---|
7D | -10.0% | -2.1% | 0.4% |
1Y | 80.0% | 3.1% | 9.0% |
Return vs Industry: AIDX exceeded the Canadian Healthcare industry which returned 3.9% over the past year.
Return vs Market: AIDX exceeded the Canadian Market which returned 9% over the past year.
Price Volatility
AIDX volatility | |
---|---|
AIDX Average Weekly Movement | 10.9% |
Healthcare Industry Average Movement | 4.6% |
Market Average Movement | 8.5% |
10% most volatile stocks in CA Market | 18.4% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: AIDX's share price has been volatile over the past 3 months.
Volatility Over Time: AIDX's weekly volatility has decreased from 25% to 11% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 340 | Alex Dobranowski | https://www.healwell.ai |
Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. It offers AI-enabled decision support for healthcare providers. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies.
Healwell AI Inc. Fundamentals Summary
AIDX fundamental statistics | |
---|---|
Market cap | CA$101.77m |
Earnings (TTM) | -CA$31.13m |
Revenue (TTM) | CA$51.84m |
2.0x
P/S Ratio-3.3x
P/E RatioIs AIDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AIDX income statement (TTM) | |
---|---|
Revenue | CA$51.84m |
Cost of Revenue | CA$36.02m |
Gross Profit | CA$15.82m |
Other Expenses | CA$46.95m |
Earnings | -CA$31.13m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Mar 28, 2024
Earnings per share (EPS) | -0.28 |
Gross Margin | 30.52% |
Net Profit Margin | -60.05% |
Debt/Equity Ratio | -136.1% |
How did AIDX perform over the long term?
See historical performance and comparison